Form 4: Innovative Medtech Director Acquires 6.5 Million Shares in Lieu of Salary

Sentiment:

SEC Form 4 Filing


Michael Jordan Friedman, a director, 10% owner, and President of Innovative Medtech, Inc., acquired 6,500,000 shares of common stock to satisfy accrued salary.

Summary

  • Michael Jordan Friedman, a director, 10% owner, and President of Innovative Medtech, Inc. (IMTH), filed a Form 4.
  • The filing reports a transaction that occurred on December 17, 2024, where Mr. Friedman acquired 6,500,000 shares of common stock.
  • These shares were acquired at a price of $0.005 per share.
  • The acquisition was made in satisfaction of accrued salary amounting to $325,000.
  • Following the transaction, Mr. Friedman directly owns no shares but indirectly owns 9,918,607 shares through Red Halo, LLC.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it simply reports a transaction. The issuance of shares in lieu of salary could be seen as slightly negative as it dilutes existing shareholders, but it also conserves cash.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders. This transaction indicates how the company is managing its cash flow and compensating its executives.

Stakeholder Impact

  • Shareholders may experience slight dilution due to the issuance of new shares.
  • The company benefits from conserving cash by issuing shares instead of paying salary in cash.

Key Dates

DateDescription
12/17/2024Date of transaction: Michael Jordan Friedman acquired 6,500,000 shares of common stock.
01/07/2025Date of signature on the Form 4 filing.

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.